Healthcare provider profile · identity verified

Renu Bansal, MD

Internal Medicine · WATERLOO, IA · NPI 1225238280

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	529	120
Levothyroxine Sodium	Levothyroxine Sodium	492	113
Furosemide	Furosemide	361	82
Amlodipine Besylate	Amlodipine Besylate	356	84
Lisinopril	Lisinopril	332	85
Gabapentin	Gabapentin	327	68
Omeprazole	Omeprazole	307	78
Losartan Potassium	Losartan Potassium	306	75
Rosuvastatin Calcium	Rosuvastatin Calcium	262	77
Pantoprazole Sodium	Pantoprazole Sodium	259	60
Metoprolol Succinate	Metoprolol Succinate	243	60
Simvastatin	Simvastatin	222	51
Hydrochlorothiazide	Hydrochlorothiazide	195	51
Warfarin Sodium	Warfarin Sodium	180	23
Metoprolol Tartrate	Metoprolol Tartrate	175	38
Potassium Chloride	Potassium Chloride	167	35
Allopurinol	Allopurinol	155	35
Metformin Hcl	Metformin Hcl	152	38
Tamsulosin Hcl	Tamsulosin Hcl	148	36
Escitalopram Oxalate	Escitalopram Oxalate	133	34
Trazodone Hcl	Trazodone Hcl	130	30
Montelukast Sodium	Montelukast Sodium	128	29
Pravastatin Sodium	Pravastatin Sodium	127	27
Alendronate Sodium	Alendronate Sodium	115	23
Oxybutynin Chloride Er	Oxybutynin Chloride	111	37
Ozempic	Semaglutide	110	15
Spironolactone	Spironolactone	92	18
Metformin Hcl Er	Metformin Hcl	90	18
Sertraline Hcl	Sertraline Hcl	88	25
Fenofibrate	Fenofibrate	83	28
Citalopram Hbr	Citalopram Hydrobromide	74	14
Venlafaxine Hcl Er	Venlafaxine Hcl	74	12
Tramadol Hcl	Tramadol Hcl	70	25
Duloxetine Hcl	Duloxetine Hcl	69	17
Jardiance	Empagliflozin	69	13
Meloxicam	Meloxicam	67	28
Fenofibrate	Fenofibrate Nanocrystallized	64	15
Finasteride	Finasteride	62	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	13
Alprazolam	Alprazolam	58	suppressed
Celecoxib	Celecoxib	58	13
Clonazepam	Clonazepam	58	suppressed
Myrbetriq	Mirabegron	57	suppressed
Prednisone	Prednisone	57	29
Glipizide	Glipizide	55	14
Clopidogrel	Clopidogrel Bisulfate	54	13
Eliquis	Apixaban	51	suppressed
Carvedilol	Carvedilol	50	13
Tizanidine Hcl	Tizanidine Hcl	50	27
Lovastatin	Lovastatin	48	12
Glipizide Er	Glipizide	47	14
Mounjaro	Tirzepatide	47	suppressed
Ropinirole Hcl	Ropinirole Hcl	45	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	42	21
Azithromycin	Azithromycin	41	37
Fluticasone Propionate	Fluticasone Propionate	41	11
Pregabalin	Pregabalin	41	11
Synthroid	Levothyroxine Sodium	41	12
Nortriptyline Hcl	Nortriptyline Hcl	40	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	35
Famotidine	Famotidine	39	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Cholestyramine	Cholestyramine (With Sugar)	38	11
Lorazepam	Lorazepam	38	suppressed
Cephalexin	Cephalexin	37	31
Triamcinolone Acetonide	Triamcinolone Acetonide	37	25
Bumetanide	Bumetanide	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	12
Zolpidem Tartrate	Zolpidem Tartrate	33	11
Fluoxetine Hcl	Fluoxetine Hcl	32	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Irbesartan	Irbesartan	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Primidone	Primidone	29	suppressed
Atenolol	Atenolol	28	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	24
Bupropion Xl	Bupropion Hcl	26	suppressed
Fenofibrate	Fenofibrate,micronized	26	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Spiriva Handihaler	Tiotropium Bromide	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Metolazone	Metolazone	23	suppressed
Nabumetone	Nabumetone	23	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	12
Propranolol Hcl	Propranolol Hcl	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Topiramate	Topiramate	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	13
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Estradiol	Estradiol	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Torsemide	Torsemide	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Unifine Pentips	Pen Needle, Diabetic	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Imipramine Hcl	Imipramine Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Saxagliptin-Metformin Er	Saxagliptin Hcl/Metformin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error